The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

It is tiresome, but not surprising, that the polarized commentary in the days since the blizzard of pardons and clemencies ...

BOSTON - Ironwood Pharmaceuticals , Inc. (NASDAQ: NASDAQ:IRWD), currently trading at $3.72 with a market capitalization of ...

Monthly Minute highlights a recent Texas court decision holding ESG investing violated ERISA and a new development in the J&J ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

Hallucinations in LLMs refer to instances where models generate plausible yet incorrect or unrelated information.

Reported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66th ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...